First choice management measure consists in the enforcement of a dopaminergic drug dosage reduction. If this decrease is maintained,<unk>  syndrome features soon decrease. Cessation of dopamine agonists therapy may also be of use. Some behavioral characteristics may respond to psychotherapy; and social support is important to control risk factors. In some cases antipsychotic drugs may also be of use in the presence of psychosis, aggression, gambling or hypersexuality. Based upon five case reports, valproic acid may have efficacy in controlling the symptoms of levodopa-induced<unk>  that arise from the use of levodopa for the treatment of Parkinson's disease.
Dopamine dysregulation syndrome
Hyperprolactinemic SAHA syndrome
Sheehan's syndrome
Autoimmune polyendocrine syndrome
Hypothalamic disease
Dopamine transporter deficiency syndrome
Gerstmann syndrome
Hypopituitarism